| 1 year | +8.3%โ lags S&P |
| 3 years | +14.7%โ beats S&P |
| 5 years | +17.2%โ beats S&P |
| 10 years | +17.6%โ beats S&P |
| 20 years | +19.1%โ beats S&P |
| All-time | +19.1% |
AbbVie Inc. (ticker: ABBV) has delivered a +17.2%/yr 5-year CAGR and a +17.6%/yr 10-year CAGR. For comparison, the S&P 500 has averaged approximately +10.5%/yr over the long run.
If you had invested $10,000 in ABBV and added $500 per month, after 30 years at its historical rate your portfolio could grow to approximately $12.0M โ compared to $1.5M in the S&P 500 at 10.5%/yr. AbbVie Inc. also pays a dividend yield of approximately 3.23% annually.
โ Past performance does not guarantee future results. This page is for educational purposes and does not constitute financial advice. Data last refreshed: 2026-03-20.
PortfolioCalc lets you combine ABBV with other stocks and ETFs, set a monthly investment, and see a detailed 30-year projection โ free, no account required.
Explore other popular tickers: